Stimuli-activatable strategies prevail in the design of nanomedicine for cancer theranostics.
Upon exposure to endogenous/exogenous stimuli, the stimuli-activatable nanomedicine …

Microenvironment-responsive drug delivery systems (DDSs) can achieve targeted drug
delivery, reduce drug side effects and improve drug efficacies. Among them, pH-responsive …

Stimuli‐responsive nanoparticles have the potential to improve the delivery of therapeutics
to a specific cell or region within the body. There are many stimuli that have shown potential …

The development of precise and personalized medicine requires novel formulation
strategies to deliver the therapeutic payloads to the pathological tissues, producing …

The repair of segmental bone defects caused by traumatic injury or pathological diseases
remains a substantial challenge in clinic. Poly-l-lactic acid (PLLA) is recognized as one …

Effective tumor treatment depends on optimizing drug penetration and accumulation in
tumor tissue while minimizing systemic toxicity. Nanomedicine has emerged as a key …

The efficacy of cancer catalytic therapy is still hindered by the inefficient generation of
reactive oxygen species (ROS). Herein, we report a self-driven electrical stimulation …

The insufficient mechanical strength and slow degradation rate of poly-L-lactic acid (PLLA)
limit its applications in bone repair. In this study, zeolitic imidazolate framework-8 (ZIF-8) …

Disulfiram (DSF) has excellent in vitro anticancer activity in the presence of Cu (II). The
anticancer mechanism studies have demonstrated that copper (II) diethyldithiocarbamate …

Doxorubicin (DOX) is a widely-used anticancer drug, but its cardiotoxicity severely hampers
its potency in chemotherapy. Herein, human serum albumin (HSA) is engaged as a …